Charles River Laboratories International Inc (CRL)
234.48
-1.45
(-0.61%)
USD |
NYSE |
Apr 16, 10:16
Charles River Laboratories International Cash from Financing (TTM): -85.52M for Dec. 31, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -85.52M |
| September 30, 2023 | -458.04M |
| June 30, 2023 | -346.77M |
| March 31, 2023 | -3.873M |
| December 31, 2022 | -42.40M |
| September 30, 2022 | -12.41M |
| June 30, 2022 | 218.08M |
| March 31, 2022 | 464.60M |
| December 31, 2021 | 672.60M |
| September 30, 2021 | 832.34M |
| June 30, 2021 | 384.81M |
| March 31, 2021 | -237.24M |
| December 31, 2020 | 47.25M |
| September 30, 2020 | 67.43M |
| June 30, 2020 | 202.63M |
| March 31, 2020 | 780.23M |
| December 31, 2019 | 231.94M |
| September 30, 2019 | 271.54M |
| June 30, 2019 | 257.91M |
| March 31, 2019 | 503.91M |
| December 31, 2018 | 558.06M |
| September 30, 2018 | 504.49M |
| June 30, 2018 | 651.16M |
| March 31, 2018 | -149.09M |
| December 31, 2017 | -208.48M |
| Date | Value |
|---|---|
| September 30, 2017 | -179.39M |
| June 30, 2017 | -284.56M |
| March 31, 2017 | 306.73M |
| December 31, 2016 | 380.76M |
| September 30, 2016 | 408.86M |
| June 30, 2016 | 566.72M |
| March 31, 2016 | -9.486M |
| December 31, 2015 | -7.258M |
| September 30, 2015 | 5.678M |
| June 30, 2015 | -80.52M |
| March 31, 2015 | 69.49M |
| December 31, 2014 | 61.41M |
| September 30, 2014 | 28.39M |
| June 30, 2014 | 23.39M |
| March 31, 2014 | -83.87M |
| December 31, 2013 | -84.24M |
| September 30, 2013 | -86.44M |
| June 30, 2013 | -75.07M |
| March 31, 2013 | -87.00M |
| December 31, 2012 | -111.12M |
| September 30, 2012 | -149.02M |
| June 30, 2012 | -227.62M |
| March 31, 2012 | -273.37M |
| December 31, 2011 | -271.79M |
| September 30, 2011 | -230.13M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-458.04M
Minimum
Sep 2023
832.34M
Maximum
Sep 2021
170.79M
Average
202.63M
Median
Jun 2020
Cash from Financing (TTM) Benchmarks
| Cardinal Health Inc | -2.545B |
| DaVita Inc | -1.170B |
| Stryker Corp | -1.594B |
| Inotiv Inc | -5.433M |
| Acadia Healthcare Co Inc | -62.70M |